Lior Nissim

Active Investor

Head of Synthetic Biology at Abintus Bio, Inc.

Jerusalem District

Lior Nissim, Head of Synthetic Biology at Abintus Bio, Inc. is an active investor based in Jerusalem District. This profile covers what Lior Nissim backs, at which stage, and how founders can reach out in 2026.

Dr. Lior Nissim is a Co-Founder and serves as Advisor at MeatoLogic. He leads the applicative synthetic biology lab at the Hebrew University of Jerusalem, Hadassah Medical School. He is an expert in the field of synthetic biology that combines biology, medicine, and engineering principles, developing synthetic biology platforms for basic research and biomedical applications. During his Ph.D. at the Weizmann Institute of Science, he developed the very first synthetic gene circuit that actuated Boolean logic to precisely target cancer cells. Dr. Nissim performed his postdoctoral training at the Massachusetts Institute of Technology (MIT) synthetic biology center.

Investor type: Angel
Stages: Pre SeedSeed
Invests in: Healthcare & BiotechBiotech & PharmaIoT & Connected Devices
Location: Jerusalem District
Typical check: $150K
Past investments: 1

Notable investments

Circuit-Bio

How to reach Lior Nissim

Angels and operators like Lior Nissim reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.

Frequently Asked Questions

What does Lior Nissim invest in?

Lior Nissim invests in Healthcare & Biotech, Biotech & Pharma and IoT & Connected Devices, typically at Pre Seed and Seed. Match your sector and stage, then reach out with a personalized pitch.